一例接受R-Bendamustine化疗的滤泡性淋巴瘤患者子宫腺肌症体积缩小的病例
本文报道一例48岁女性滤泡性淋巴瘤患者,[18F]FDG PET/CT显示多发高代谢淋巴结及轻度高代谢的子宫腺肌症,接受R-Bendamustine化疗后子宫腺肌症体积和代谢均下降,同时雌二醇水平降低并出现闭经和潮热,诊断为化疗诱导的早期绝经。
要点
- 滤泡性淋巴瘤患者接受R-Bendamustine化疗后子宫腺肌症体积和代谢下降。
- [18F]FDG PET/CT可显示子宫腺肌症伴轻度高代谢。
- 化疗后雌二醇水平降低,患者出现闭经和潮热,诊断为化疗诱导的早期绝经。
核心结论
- 接受R-Bendamustine化疗的滤泡性淋巴瘤患者子宫腺肌症体积和代谢下降,同时出现化疗诱导的早期绝经。
研究设计与样本
- 病例报告,描述一例48岁女性滤泡性淋巴瘤患者的临床过程。
主要发现
- [18F]FDG PET/CT显示双侧颈部、腋窝、纵隔、肠系膜、腹膜后、髂及腹股沟区多发高代谢淋巴结,并显示子宫腺肌症伴轻度高代谢。
- R-Bendamustine化疗后子宫腺肌症体积和代谢下降。
- 化疗后雌二醇水平降低,患者出现闭经和潮热,诊断为化疗诱导的早期绝经。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We describe a case of adenomyosis that reduced in size in a patient with lymphoma on receiving chemotherapy. A 48-year-old woman with worsening left flank pain was diagnosed with follicular lymphoma. [ 18 F]FDG PET/CT revealed multiple hypermetabolic lymph nodes in the bilateral cervical, axillary, mediastinal, mesenteric, retroperitoneal, iliac, and inguinal regions. In addition, adenomyosis with mild hypermetabolism was demonstrated on [ 18 F]FDG PET/CT. The size and metabolism of adenomyosis decreased after chemotherapy with R-bendamustine; in addition, along with decrease in estradiol levels, the patient experienced amenorrhea and hot flushes. The patient was diagnosed with chemotherapy-induced early menopause.
引用
- Seo M, Lee YJ, Choi HJ, et al. A Case of Adenomyosis Showing Size Reduction in a Follicular Lymphoma Patient Receiving Chemotherapy With R-Bendamustine. Clin Nucl Med. 2023. PMID: 37351856. doi:10.1097/RLU.0000000000004755
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。